EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Preliminary Evaluation of Middle Ear Resonance Frequency via Wideband Tympanometry in Patients with Non-Alcoholic Fatty Liver Disease

Mustafa Taştan, Alihan Oral, Tuğba Yemiş

Journal of Clinical Medicine · 08.07.2026 · 15 (14) · 5335

DOI: 10.3390/jcm15145335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.07.2026. Verfasst von Mustafa Taştan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Istinye University, Istanbul 34010, Türkiye. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recep Tayyip Erdogan University Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Non-alcoholic fatty liver disease (NAFLD) induces systemic low-grade inflammation and lipotoxicity. While its microvascular effects on the inner ear are recognized, its impact on the middle ear remains unexplored. This study aimed to investigate subclinical biomechanical alterations in the middle ear of normal-hearing NAFLD patients using Wideband Tympanometry (WBT). Materials and Methods: This prospective observational study included 28 patients with ultrasonographically confirmed NAFLD and 30 healthy, sex-matched controls. All included participants had normal pure-tone hearing thresholds and Type A tympanograms. WBT was performed to measure Resonance Frequency (RF) and frequency-specific absorbance (226–8000 Hz). A subgroup analysis compared early-stage (Grade 1) and advanced-stage (Grades 2–3) hepatosteatosis.

Results

The mean RF was significantly lower in the NAFLD group compared to the controls for both the right (781.6 ± 218.7 vs. 1010.6 ± 529.0 Hz; p = 0.035) and left ears (740.3 ± 212.7 vs. 1221.6 ± 754.2 Hz; p = 0.002). Furthermore, wideband absorbance was significantly elevated at lower frequencies (250 Hz and 500 Hz) in the study group (p < 0.001 for both ears). Middle ear resting pressures were similar between the groups. Subgroup analysis revealed no significant differences in WBT parameters between Grade 1 and advanced stages (p > 0.05).

Conclusions

Normal-hearing NAFLD patients exhibit a mass-dominated biomechanical shift in the middle ear, characterized by a decreased RF and increased low-frequency absorbance. These subclinical alterations, observable even in early-stage hepatosteatosis, likely reflect mucosal micro-edema driven by systemic inflammation. WBT serves as a sensitive, non-invasive tool for detecting early metabolic-related otologic changes.

Schlagwörter

Stichwörter der Autor:innen

middle ear absorbancenon-alcoholic fatty liver diseaseresonance frequencysystemic inflammationwideband tympanometry

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Istinye University, Istanbul 34010, Türkiye.
  • Department of Internal Medicine, Faculty of Medicine, Biruni University, Istanbul 34010, Türkiye.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, Türkiye.

Förderung

  • Recep Tayyip Erdogan University Development Foundation

Zitieren

APA

Taştan, M., Oral, A., & Yemiş, T. (2026). A Preliminary Evaluation of Middle Ear Resonance Frequency via Wideband Tympanometry in Patients with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine, 15(14), 5335. https://doi.org/10.3390/jcm15145335

Vancouver

Taştan M, Oral A, Yemiş T. A Preliminary Evaluation of Middle Ear Resonance Frequency via Wideband Tympanometry in Patients with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine. 2026;15(14):5335. doi:10.3390/jcm15145335

BibTeX
@article{Tatan2026,
  author = {Taştan, Mustafa and Oral, Alihan and Yemiş, Tuğba},
  title = {A Preliminary Evaluation of Middle Ear Resonance Frequency via Wideband Tympanometry in Patients with Non-Alcoholic Fatty Liver Disease},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {5335},
  doi = {10.3390/jcm15145335}
}
Kostenlos starten →